Abstract 219
| 2003 (before pre assessment) | 2004 (after pre assessment) | |
|---|---|---|
| n (male: female) | 52 (19M:33F) | 50 (22M:28F) |
| Median age (range) | 78.5 y (28–96) | 76.5 y (31–96) |
| Indications for PEG: | ||
| CVA | 28 | 31 |
| Dementia | 5 | 4 |
| Parkinson’s disease | 4 | 3 |
| Multiple sclerosis | 4 | 2 |
| Others | 11 | 10 |
| PEGS declined after pre-assessment | Not applicable | 16 (24%) comprising: poor clinical condition, 6; already on oral diet, 5; high INR, 2; other, 3 |
| Survival: 7 day/30 day/6 month | 87%/78%/61% | 96%/88%/74% |